Sunrest Lifescience reports consolidated net profit of ₹411.63 lakh in FY26
Sunrest Lifescience reported a consolidated net profit of ₹411.63 lakh for FY26, up from ₹200.56 lakh in the previous year, with revenue rising to ₹7083.29 lakh. Standalone net profit increased to ₹308.86 lakh. The board approved the audited financial results and appointed M/S. VRCA & Associates as internal auditor for FY27.
*this image is generated using AI for illustrative purposes only.
Sunrest Lifescience reported a consolidated net profit of ₹411.63 lakh for the financial year ended March 31, 2026, a significant increase from ₹200.56 lakh in the previous year. The company’s consolidated revenue from operations for FY26 stood at ₹7083.29 lakh, compared to ₹3341.30 lakh in FY25. The board of directors approved the standalone and consolidated audited financial results for the half year and year ended March 31, 2026, during a meeting held on May 29, 2026.
Financial Performance
The consolidated financial results include the performance of subsidiary Hetvi Lifesciences Private Limited. For the year ended March 31, 2026, the company reported a total income of ₹7333.97 lakh. Profit before tax for the period was ₹1010.32 lakh, with a total tax expense of ₹210.88 lakh. The statutory auditors, Madhusudan C Mashruwala & Co, issued an audit report with an unmodified opinion on the standalone and consolidated financial results.
Standalone Results
On a standalone basis, Sunrest Lifescience reported a net profit of ₹308.86 lakh for FY26, up from ₹199.98 lakh in the previous year. Revenue from operations for the standalone entity increased marginally to ₹3326.05 lakh from ₹3312.24 lakh in FY25. Total expenses for the year were ₹2918.34 lakh, a decrease from ₹3051.45 lakh in the prior year.
Key Standalone Metrics (FY26)
| Particulars | Amount (₹ in lakhs) |
|---|---|
| Revenue from operations | 3326.05 |
| Total Income | 3326.37 |
| Total Expenses | 2918.34 |
| Profit for the period | 308.86 |
| Earnings per share (Basic) | 7.20 |
Board Decisions
In addition to approving the financial results, the board appointed M/S. VRCA & Associates as the internal auditor for the financial year 2026-27, based on the recommendation of the audit committee. The firm registration number is 104727W. The company has not adopted Indian Accounting Standards (Ind AS) due to the exemption available to companies listed on the EMERGE Platform of NSE.
Historical Stock Returns for Sunrest Lifescience
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.86% | -7.61% | -5.82% | -19.14% | -32.07% | -57.39% |
What strategic initiatives drove the revenue growth at subsidiary Hetvi Lifesciences?
Will the company consider transitioning to Indian Accounting Standards (Ind AS) as it scales?
How does Sunrest plan to sustain the standalone revenue growth given the marginal increase in FY26?
15
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
